ACHL
Achilles Therapeutics PLC ADR
NASDAQ: ACHL · HEALTHCARE · BIOTECHNOLOGY
$1.48
+0.00% today
Updated 2026-04-29
Market cap
$63.22M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.66
Dividend yield
—
52W range
$0 – $0
Volume
1.2M
Achilles Therapeutics PLC ADR (ACHL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-52.10%
ROA
-30.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-6.89M | — | — | — |
| 2019 | $0.00 | $-13.99M | — | — | — |
| 2020 | $0.00 | $-33.20M | — | — | — |
| 2021 | $0.00 | $-61.10M | — | — | — |
| 2022 | $0.00 | $-71.18M | — | — | — |
| 2023 | $0.00 | $-69.67M | — | — | — |